18 results
424B5
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Prospectus supplement for primary offering
5:27pm
. These provisions include:
reduced executive compensation disclosure;
S-4
exemptions from the requirement to hold a non-binding advisory vote on executive … advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
We may take advantage
424B3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Prospectus supplement
4:03pm
obligations regarding executive compensation in periodic reports, proxy statements and registration statements; and
exemptions from the requirements … of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
We may take
F-3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
5 Dec 23
Shelf registration (foreign)
4:06pm
of our internal control over financial reporting;
reduced disclosure obligations regarding executive compensation in periodic reports, proxy statements … and registration statements; and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
31 Oct 23
Current report (foreign)
4:38pm
for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting
424B3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
31 Mar 23
Prospectus supplement
4:04pm
internal control over financial reporting;
reduced disclosure obligations regarding executive compensation in periodic reports, proxy statements … and registration statements; and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval
424B3
t7s482p36f6j5clioxed
2 Dec 22
Prospectus supplement
4:17pm
F-1
nt7exodoz0xciq5
18 Nov 22
Registration statement (foreign)
5:39pm
6-K
EX-99.2
1094oy l3fbsji2
26 Jul 22
Current report (foreign)
7:36am
424B4
6wbrc82k39i6g8a13hz
21 Jul 22
Prospectus supplement with pricing info
10:01am
F-1/A
rspt6jw
24 Jun 22
Registration statement (foreign) (amended)
9:47pm
F-1/A
xxncap 1nvaemmls
24 Jun 22
Registration statement (foreign) (amended)
8:21am
F-1/A
jxr017bg
21 Jun 22
Registration statement (foreign) (amended)
6:26am
F-1/A
it4r2sk 8ovhjx46fu
6 Jun 22
Registration statement (foreign) (amended)
6:13pm
F-1/A
pfbouzrp0
11 May 22
Registration statement (foreign) (amended)
3:11pm
F-1/A
1qdhzr 1ul
22 Apr 22
Registration statement (foreign) (amended)
6:09pm
F-1
fk7jk7at0v1 q1rmbo
18 Mar 22
Registration statement (foreign)
3:50pm
DRS/A
l4zfzr4 naotm2
17 Feb 22
Draft registration statement (amended)
12:00am
DRS
c2ax ivd10zaqd
27 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next